Avorelin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAvorelin
Drug Alias Nameavorelina阿伏瑞林avorelinumMeterelinEP-23904 +[6] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGonadotropin-releasing hormone agonists
TargetsGonadotropin-releasing hormone
Therapy Area/IndicationsEndometriosisProstatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMediolanum Farmaceutici Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMediolanum Farmaceutici Spa
Active IndicationsN/A
Inactive IndicationsEndometriosisProstatic NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A